BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $92,300,000 | +89.7% | 610,571 | +82.9% | 0.28% | +79.1% |
Q2 2022 | $48,644,000 | +916.6% | 333,839 | +869.2% | 0.16% | +690.0% |
Q3 2021 | $4,785,000 | +309.7% | 34,446 | +152.8% | 0.02% | +233.3% |
Q4 2020 | $1,168,000 | -77.1% | 13,627 | -88.9% | 0.01% | -82.9% |
Q3 2019 | $5,099,000 | +19.6% | 122,231 | +25.6% | 0.04% | +29.6% |
Q2 2019 | $4,263,000 | -56.5% | 97,341 | -63.2% | 0.03% | -62.0% |
Q4 2018 | $9,795,000 | +3527.8% | 264,861 | +3577.6% | 0.07% | +7000.0% |
Q3 2018 | $270,000 | -51.9% | 7,202 | -49.3% | 0.00% | -66.7% |
Q2 2018 | $561,000 | – | 14,207 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |